Robert Bailey

Title: Innovations of Robert Bailey in Biopharmaceutical Purification

Introduction

Robert Bailey is an accomplished inventor based in Bothell, WA (US), known for his significant contributions to the field of biopharmaceutical purification. With a total of three patents to his name, Bailey has developed innovative methods that enhance the efficiency and effectiveness of purification processes in the biopharmaceutical industry.

Latest Patents

One of Bailey's latest patents is a method for using light scattering in real time to directly monitor and control impurity removal in purification processes. This invention provides a novel approach to controlling contaminants in biopharmaceutical purification by utilizing light scattering and UV absorbance to establish a determinant. The method employs multi-angle light scattering (MALS) and UV as a continuous monitoring system, offering real-time information about elution peak fractions. This advancement stands in contrast to conventional pooling methods, which depend on a predetermined percent UV peak max value to initiate the pooling process, regardless of product quality.

Career Highlights

Bailey's career is marked by his role at Amgen Inc., a leading biopharmaceutical company. His work focuses on improving purification processes, which are critical for ensuring the quality and safety of biopharmaceutical products. His innovative methods have the potential to revolutionize how contaminants are monitored and controlled during purification.

Collaborations

Throughout his career, Bailey has collaborated with notable colleagues, including Arthur C Hewig, III and Duke H Phan. These collaborations have contributed to the development of his patents and the advancement of purification technologies in the biopharmaceutical sector.

Conclusion

Robert Bailey's contributions to biopharmaceutical purification through his innovative patents demonstrate his commitment to enhancing industry standards. His work not only improves purification processes but also ensures the safety and quality of biopharmaceutical products.